Antiretroviral Drug Resistance and Routine Therapy, Cameroon

Among 128 patients routinely receiving highly active antiretroviral therapy in an HIV/AIDS outpatient clinic in Cameroon, 16.4% had drug resistance after a median of 10 months. Of these, 12.5% had resistance to nucleoside reverse transcriptase inhibitors (NRTIs), 10.2% to non-NRTIs, and 2.3% to prot...

Descripción completa

Detalles Bibliográficos
Autores principales: Laurent, Christian, Kouanfack, Charles, Vergne, Laurence, Tardy, Michèle, Zekeng, Léopold, Noumsi, Nathalie, Butel, Christelle, Bourgeois, Anke, Mpoudi-Ngolé, Eitel, Koulla-Shiro, Sinata, Peeters, Martine, Delaporte, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2006
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298273/
https://www.ncbi.nlm.nih.gov/pubmed/16707062
http://dx.doi.org/10.3201/eid1206.050860
_version_ 1782225972008845312
author Laurent, Christian
Kouanfack, Charles
Vergne, Laurence
Tardy, Michèle
Zekeng, Léopold
Noumsi, Nathalie
Butel, Christelle
Bourgeois, Anke
Mpoudi-Ngolé, Eitel
Koulla-Shiro, Sinata
Peeters, Martine
Delaporte, Eric
author_facet Laurent, Christian
Kouanfack, Charles
Vergne, Laurence
Tardy, Michèle
Zekeng, Léopold
Noumsi, Nathalie
Butel, Christelle
Bourgeois, Anke
Mpoudi-Ngolé, Eitel
Koulla-Shiro, Sinata
Peeters, Martine
Delaporte, Eric
author_sort Laurent, Christian
collection PubMed
description Among 128 patients routinely receiving highly active antiretroviral therapy in an HIV/AIDS outpatient clinic in Cameroon, 16.4% had drug resistance after a median of 10 months. Of these, 12.5% had resistance to nucleoside reverse transcriptase inhibitors (NRTIs), 10.2% to non-NRTIs, and 2.3% to protease inhibitors.
format Online
Article
Text
id pubmed-3298273
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-32982732012-03-14 Antiretroviral Drug Resistance and Routine Therapy, Cameroon Laurent, Christian Kouanfack, Charles Vergne, Laurence Tardy, Michèle Zekeng, Léopold Noumsi, Nathalie Butel, Christelle Bourgeois, Anke Mpoudi-Ngolé, Eitel Koulla-Shiro, Sinata Peeters, Martine Delaporte, Eric Emerg Infect Dis Dispatch Among 128 patients routinely receiving highly active antiretroviral therapy in an HIV/AIDS outpatient clinic in Cameroon, 16.4% had drug resistance after a median of 10 months. Of these, 12.5% had resistance to nucleoside reverse transcriptase inhibitors (NRTIs), 10.2% to non-NRTIs, and 2.3% to protease inhibitors. Centers for Disease Control and Prevention 2006-06 /pmc/articles/PMC3298273/ /pubmed/16707062 http://dx.doi.org/10.3201/eid1206.050860 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Laurent, Christian
Kouanfack, Charles
Vergne, Laurence
Tardy, Michèle
Zekeng, Léopold
Noumsi, Nathalie
Butel, Christelle
Bourgeois, Anke
Mpoudi-Ngolé, Eitel
Koulla-Shiro, Sinata
Peeters, Martine
Delaporte, Eric
Antiretroviral Drug Resistance and Routine Therapy, Cameroon
title Antiretroviral Drug Resistance and Routine Therapy, Cameroon
title_full Antiretroviral Drug Resistance and Routine Therapy, Cameroon
title_fullStr Antiretroviral Drug Resistance and Routine Therapy, Cameroon
title_full_unstemmed Antiretroviral Drug Resistance and Routine Therapy, Cameroon
title_short Antiretroviral Drug Resistance and Routine Therapy, Cameroon
title_sort antiretroviral drug resistance and routine therapy, cameroon
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298273/
https://www.ncbi.nlm.nih.gov/pubmed/16707062
http://dx.doi.org/10.3201/eid1206.050860
work_keys_str_mv AT laurentchristian antiretroviraldrugresistanceandroutinetherapycameroon
AT kouanfackcharles antiretroviraldrugresistanceandroutinetherapycameroon
AT vergnelaurence antiretroviraldrugresistanceandroutinetherapycameroon
AT tardymichele antiretroviraldrugresistanceandroutinetherapycameroon
AT zekengleopold antiretroviraldrugresistanceandroutinetherapycameroon
AT noumsinathalie antiretroviraldrugresistanceandroutinetherapycameroon
AT butelchristelle antiretroviraldrugresistanceandroutinetherapycameroon
AT bourgeoisanke antiretroviraldrugresistanceandroutinetherapycameroon
AT mpoudingoleeitel antiretroviraldrugresistanceandroutinetherapycameroon
AT koullashirosinata antiretroviraldrugresistanceandroutinetherapycameroon
AT peetersmartine antiretroviraldrugresistanceandroutinetherapycameroon
AT delaporteeric antiretroviraldrugresistanceandroutinetherapycameroon

Ejemplares similares